These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30386138)

  • 1. Optimal Phase of Dynamic Computed Tomography for Reliable Size Measurement of Metastatic Neuroendocrine Tumors of the Liver: Comparison between Pre- and Post-Contrast Phases.
    Huh J; Park J; Kim KW; Kim HJ; Lee JS; Lee JH; Jeong YK; Shinagare AB; Ramaiya NH
    Korean J Radiol; 2018; 19(6):1066-1076. PubMed ID: 30386138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver metastases of neuroendocrine tumors: is it possible to diagnose different histologic subtypes depending on multiphasic CT features?
    Gulpinar B; Peker E; Kul M; Elhan AH; Haliloglu N
    Abdom Radiol (NY); 2019 Jun; 44(6):2147-2155. PubMed ID: 30863999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypervascular liver metastases: do unenhanced and hepatic arterial phase CT images affect tumor detection?
    Oliver JH; Baron RL; Federle MP; Jones BC; Sheng R
    Radiology; 1997 Dec; 205(3):709-15. PubMed ID: 9393525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement variability of liver metastases from neuroendocrine tumors on different magnetic resonance imaging sequences.
    Lestra T; Kanagaratnam L; Mulé S; Janvier A; Brixi H; Cadiot G; Dohan A; Hoeffel C
    Diagn Interv Imaging; 2018 Feb; 99(2):73-81. PubMed ID: 29339222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are we reproducible in measurement of NET liver metastasis?
    Moalla S; Arfi Rouche J; Foulon S; Caramella C; Ternes N; Planchard D; Goere D; Ducreux M; Scoazec JY; Deschamps F; Dromain C; Baudin E
    Dig Liver Dis; 2017 Oct; 49(10):1121-1127. PubMed ID: 28844707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duodenal neuroendocrine tumors: retrospective evaluation of CT imaging features and pattern of metastatic disease on dual-phase MDCT with pathologic correlation.
    Tsai SD; Kawamoto S; Wolfgang CL; Hruban RH; Fishman EK
    Abdom Imaging; 2015 Jun; 40(5):1121-30. PubMed ID: 25504375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of hepatic abscess from metastasis on contrast-enhanced dynamic computed tomography in patients with a history of extrahepatic malignancy: emphasis on dynamic change of arterial rim enhancement.
    Oh JG; Choi SY; Lee MH; Lee JE; Yi BH; Kim SS; Min JH; Lee B
    Abdom Radiol (NY); 2019 Feb; 44(2):529-538. PubMed ID: 30196363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is diffusion-weighted MRI sufficient for follow-up of neuroendocrine tumour liver metastases?
    Lavelle LP; O'Neill AC; McMahon CJ; Cantwell CP; Heffernan EJ; Malone DE; Daly L; Skehan SJ
    Clin Radiol; 2016 Sep; 71(9):863-8. PubMed ID: 27345612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting hepatocellular carcinoma: value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging.
    Oliver JH; Baron RL; Federle MP; Rockette HE
    AJR Am J Roentgenol; 1996 Jul; 167(1):71-7. PubMed ID: 8659425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Magnetic Resonance (MR) Biomarkers for Assessment of Response With Response Evaluation Criteria in Solid Tumors: Comparison of the Measurements of Neuroendocrine Tumor Liver Metastases (NETLM) With Various MR Sequences and at Multiple Phases of Contrast Administration.
    Luersen GF; Wei W; Tamm EP; Bhosale PR; Szklaruk J
    J Comput Assist Tomogr; 2016; 40(5):717-22. PubMed ID: 27636124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR diagnosis of hepatic metastases from neuroendocrine tumors versus hemangiomas: relative merits of dynamic gadolinium chelate-enhanced gradient-recalled echo and unenhanced spin-echo images.
    Soyer P; Gueye C; Somveille E; Laissy JP; Scherrer A
    AJR Am J Roentgenol; 1995 Dec; 165(6):1407-13. PubMed ID: 7484575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
    Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
    Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-phase helical CT of the liver: value of an early-phase acquisition in the differential diagnosis of noncystic focal lesions.
    Van Hoe L; Baert AL; Gryspeerdt S; Vandenbosh G; Nevens F; Van Steenbergen W; Marchal G
    AJR Am J Roentgenol; 1997 May; 168(5):1185-92. PubMed ID: 9129409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is a single portal venous phase in contrast-enhanced CT sufficient to detect metastases or recurrence in clear cell renal cell carcinoma? - a single-center retrospective study.
    Hagen F; Peisen F; Spogis J; Mair A; Nikolaou K; Stenzl A; Kruck S; Bedke J; Kaufmann S; Thaiss WM
    Cancer Imaging; 2022 Jan; 22(1):9. PubMed ID: 35063030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal liver masses: enhancement patterns on contrast-enhanced images--concordance of US scans with CT scans and MR images.
    Burns PN; Wilson SR
    Radiology; 2007 Jan; 242(1):162-74. PubMed ID: 17090710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of neuroendocrine liver metastases with MnDPDP-enhanced MRI.
    Rockall AG; Planche K; Power N; Nowosinska E; Monson JP; Grossman AB; Reznek RH
    Neuroendocrinology; 2009; 89(3):288-95. PubMed ID: 19023191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual phase helical CT versus portal venous phase CT for the detection of colorectal liver metastases: correlation with intra-operative sonography, surgical and pathological findings.
    Scott DJ; Guthrie JA; Arnold P; Ward J; Atchley J; Wilson D; Robinson PJ
    Clin Radiol; 2001 Mar; 56(3):235-42. PubMed ID: 11247703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 68Ga-DOTATOC PET/CT of neuroendocrine tumors: spotlight on the CT phases of a triple-phase protocol.
    Ruf J; Schiefer J; Furth C; Kosiek O; Kropf S; Heuck F; Denecke T; Pavel M; Pascher A; Wiedenmann B; Amthauer H
    J Nucl Med; 2011 May; 52(5):697-704. PubMed ID: 21498531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitative and quantitative image analysis of CT and MR imaging in patients with neuroendocrine liver metastases in comparison to (68)Ga-DOTATOC PET.
    Flechsig P; Zechmann CM; Schreiweis J; Kratochwil C; Rath D; Schwartz LH; Schlemmer HP; Kauczor HU; Haberkorn U; Giesel FL
    Eur J Radiol; 2015 Aug; 84(8):1593-1600. PubMed ID: 25999064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High sensitivity of diffusion-weighted MR imaging for the detection of liver metastases from neuroendocrine tumors: comparison with T2-weighted and dynamic gadolinium-enhanced MR imaging.
    d'Assignies G; Fina P; Bruno O; Vullierme MP; Tubach F; Paradis V; Sauvanet A; Ruszniewski P; Vilgrain V
    Radiology; 2013 Aug; 268(2):390-9. PubMed ID: 23533288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.